Stocks Health care SMTI
NASDAQ · Health careSanara MedTech Inc. (SMTI)
Sanara MedTech Inc. brought in $109.8M of revenue over the twelve months to June 30, 2026, up 13.0% from a year earlier. It posted a net loss of $32M. Operating cash flow minus capital spending left $2.2M of free cash flow in fiscal 2025. At June 30, 2026 it held $15.4M in cash against $46.5M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 11, 2026.
Key facts about Sanara MedTech Inc.
- Net worth
- Sanara MedTech Inc. has a market value (market cap) of $294.9M at the latest share price, and shareholders' equity of $7.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $103.1M (+19.0% year on year), with a net loss of $37.6M. Over the 12 months to June 30, 2026: revenue $109.8M, net loss $32M.
- Cash flow
- In fiscal 2025 operations brought in $6.8M of cash; after $4.6M of capital spending, free cash flow was $2.2M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 11, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Sanara MedTech Inc.'s next report was expected around October 20, 2026 and is not on file with the SEC yet.
What Sanara MedTech Inc. does
Sanara MedTech Inc. is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker SMTI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $103.1M | -$37.6M | -$4.36 | $2.2M |
| 2024 | $86.7M | -$9.7M | -$1.14 | -$229.6K |
| 2023 | $65M | -$4.3M | -$0.52 | -$3.5M |
| 2022 | $45.8M | -$7.9M | -$1.00 | -$5.7M |
| 2021 | $24.1M | -$7.9M | -$1.08 | -$5M |
| 2020 | $15.6M | -$4.4M | -$0.76 | -$4.6M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where SMTI ranks in Health care
Latest SEC filings
What Sanara MedTech Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 9, 2026Passive stake (5% or more) SCHEDULE 13G
- October 29, 2026
- October 16, 2026Form 425 filing 425
- October 16, 2026Other event 8-K
- October 1, 2026
- September 4, 2026Merger proxy statement DEFM14A
- August 20, 2026Form 425 filing 425
- August 11, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 9% to $28.1M versus the same quarter last year; diluted EPS -$0.05 versus -$0.23.
- August 11, 2026Form 425 filing 425
- August 11, 2026
What is SMTI worth? A DCF from its reported cash flow
Insider trades
What the people running Sanara MedTech Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 15, 2026 | Yon Seth DChief Executive Officer, Director | Shares withheld for tax | 3,661 | $128.5K |
| June 4, 2026 | DeSutter Robert AndrewDirector | Received as pay | 5,539 | - |
| June 4, 2026 | Mack Roszell IIIDirector | Received as pay | 5,308 | - |
| June 4, 2026 | Major Eric DDirector | Received as pay | 4,846 | - |
| June 4, 2026 | Myers Keith GDirector | Received as pay | 4,385 | - |
| June 4, 2026 | Nixon Ronald TDirector, 10% owner | Received as pay | 4,154 | - |
| June 4, 2026 | Ortwein Sara NDirector | Received as pay | 4,616 | - |
| June 4, 2026 | Salamone Ann BealDirector | Received as pay | 4,154 | - |
Who owns SMTI
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| The Goldman Sachs Group, Inc.13G, passive with 1 related filers | 5% | November 9, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 75 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 248,827 | +20,060 |
| Vanguard Capital Management LLC | 194,897 | +43,530 |
| Royal Bank of Canada | 130,995 | -394 |
| Stonebridge Wealth Management, LLC | 129,452 | -7,447 |
| Aqr Capital Management LLC | 112,207 | +72,269 |
| Geode Capital Management, LLC | 89,179 | +3,517 |
| Goldman Sachs Group Inc | 74,198 | +52,613 |
| Renaissance Technologies LLC | 67,400 | +2,720 |
| State Street Corp | 63,469 | +780 |
| Squarepoint Ops LLC | 53,811 | -19,796 |
| Jane Street Group, LLC | 50,806 | +12,222 |
| Marshall Wace, Llp | 49,457 | -26,825 |
| Citadel Advisors LLC | 36,813 | +5,700 |
| Northern Trust Corp | 36,441 | +3,185 |
| Jacobs Levy Equity Management, Inc | 31,644 | new |
| Walleye Capital LLC | 30,465 | new |
| Los Angeles Capital Management LLC | 26,830 | new |
| Vanguard Fiduciary Trust Co | 26,027 | +652 |
| Evernest Financial Advisors, LLC | 25,700 | new |
| Morgan Stanley | 23,628 | +3,988 |
Insiders
12 insiders reported holding 370,435 shares in total, about $11.9M at the last price.
| Holder | Shares |
|---|---|
| Yon Seth DChief Executive Officer, Director | 105,885 |
| Nixon Ronald TDirector, 10% owner | 68,196 |
| DeSutter Robert AndrewDirector | 28,740 |
| Salamone Ann BealDirector | 26,858 |
| Ortwein Sara NDirector | 25,415 |
| Waldrop Jacob A.Chief Operating Officer | 24,377 |
| Tanzberger Eric DDirector | 22,966 |
| Mack Roszell IIIDirector | 21,842 |
| Taylor Elizabeth BChief Financial Officer | 17,632 |
| Major Eric DDirector | 14,232 |
Questions about SMTI
What does Sanara MedTech Inc. do?
Sanara MedTech Inc. is a company in the Health care sector, listed on NASDAQ as SMTI. Its shares trade on NASDAQ under the ticker SMTI.
What is Sanara MedTech Inc.'s net worth?
Sanara MedTech Inc. has a market value (market cap) of $294.9M at the latest share price, and shareholders' equity of $7.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Sanara MedTech Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $32M on revenue of $109.8M.
How much revenue does Sanara MedTech Inc. make?
Over the twelve months to June 30, 2026 Sanara MedTech Inc. reported revenue of $109.8M. That is 13.0% more than a year earlier.
When did Sanara MedTech Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 11, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake (5% or more) from November 9, 2026.
When is Sanara MedTech Inc.'s next earnings report?
Sanara MedTech Inc.'s next report was expected around October 20, 2026 and is not on file with the SEC yet.
Similar companies
Compare SMTI with
Follow SMTI
Get an email when Sanara MedTech Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Sanara MedTech Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.